Acquisition - May 10, 2015
AZ to Build Plant In Algeria
AstraZeneca is part of a joint venture to build a $125 million plant in North Africa. The company established AstraZeneca al-Djazair, with two companies in Algeria, Salhi and Hasnaoui, to construct the facility. Algerian law requires that local companies have the majority ownership, so AstraZeneca will have a 49 percent interest, invest the $125 million to […]
Acquisition - May 8, 2015
Gilead Buys EpiTherapeutics ApS
Gilead Sciences, Inc., has acquired EpiTherapeutics ApS for $65 million, subject to certain purchase price adjustments, to be financed through available cash on hand, according to FierceBiotech. EpiTherapeutics has a library of small molecule inhibitors of epigenetic regulation of gene transcription, in particular histone demethylases. The company’s lead pre-clinical compounds are being evaluated for the treatment of […]
Acquisition - May 6, 2015
AZ Partnering with Flagship
Venture capital and creation firm Flagship Ventures has formed three new strategic partnerships withAstraZeneca, Nestlé Health Science and Bayer CropScience. Flagship, which manages $1.4 billion in capital, is perhaps best known for the eight successful IPOs it has backed in the past two years, as well as the formation of 27 companies to date, according […]
Acquisition - April 28, 2015
Unnamed Bidders Approach Sobi
Swedish Orphan Biovitrum (Sobi) has been approached by bidders, but the company is not revealing the names of the interested parties. The company recently issued a statement saying “that it has received a preliminary and conditional non-binding proposal in relation to a possible offer for all shares issued by the company.” Word of the proposed takeover […]
Acquisition - April 27, 2015
Karo Bio Acquires Tanomed
Recently Karo Bio acquired 100 percent of the drug research company Tanomed AB for 20 MSEK. This deal gives Karo Bio access to Tanomed’s nasal spray to relieve and prevent the progression of the common cold by reinforcing the body’s own defenses, according to Biotech Umeå. The patented technology is based on Swedish research in […]
Acquisition - April 24, 2015
MD Biomedical Joins Senzime
Umeå spin-off and medtech company MD Biomedical has been acquired by Swedish company Senzime as a subsidiary, according to Biotech Umeå. MD Biomedical has developed a probe called Onzurf, which can be used to monitor the status of an organ from the surface. The development was based on MD Biomedical’s research at Umeå University and […]
